FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$39.21 B | $44.92 B | $42.86 B | $42.88 B | $44.56 B | $46.34 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$19.58 B | $25.90 B | $25.66 B | $25.15 B | $27.78 B | $27.63 B |
Gross Profit Revenue minus cost of revenue. |
|
$19.63 B | $19.01 B | $17.19 B | $17.73 B | $16.78 B | $18.71 B |
|
Operating Expense
Costs to run business. 
|
|
$9.32 B | $10.49 B | $9.75 B | $10.07 B | $8.67 B | $10.52 B |
Operating Income Profit from operations. |
|
$10.32 B | $8.53 B | $7.45 B | $7.66 B | $8.11 B | $8.20 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$493.00 M | -$454.00 M | -$612.00 M | -$576.00 M | -$426.00 M | -$535.00 M |
Non-Operating Income (ex-Int) Income outside core operations. |
|
$941.00 M | -$36.00 M | -$343.00 M | -$1.03 B | - | -$427.00 M |
Total Other Income (Net) Net non-operating items. |
|
-$1.48 B | -$862.00 M | -$1.21 B | -$667.00 M | -$842.00 M | -$586.00 M |
Income Before Tax Profit before taxes. |
|
$8.84 B | $7.66 B | $6.24 B | $7.00 B | $7.27 B | $7.61 B |
Income Tax Expense Taxes on income. |
|
$1.11 B | $703.00 M | $284.00 M | $657.00 M | $547.00 M | $597.00 M |
|
Net Income
Final profit.
|
|
$7.73 B | $6.95 B | $6.00 B | $6.34 B | $6.74 B | $6.98 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$19.61 | $17.73 | $15.53 | $16.58 | $17.77 | $18.62 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$19.46 | $17.64 | $15.45 | $16.53 | $17.74 | $18.59 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
394.00 M | 392.00 M | 386.00 M | 382.00 M | 376.00 M | 371.00 M |
Diluted Average Shares Outst. Shares including dilution. |
|
397.00 M | 394.00 M | 388.00 M | 383.00 M | 377.00 M | 371.00 M |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$9.38 B | $8.56 B | $7.79 B | $8.69 B | $8.11 B | $8.63 B |
EBITDA Earnings before interest, tax, D&A. |
|
$11.97 B | $11.94 B | $11.20 B | $11.80 B | $10.89 B | $10.94 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$2.59 B | $3.38 B | $3.41 B | $3.11 B | $2.78 B | $2.31 B |
| Company Report |
FY 2025
Thermo Fisher Scientific's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
Thermo Fisher Scientific's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
Thermo Fisher Scientific's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
Thermo Fisher Scientific's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
